Domača stranCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
Prejšnji trg. dan.
163,64 $
Dnevni razpon
159,65 $ - 163,00 $
Letni razpon
159,65 $ - 275,00 $
Tržna kapitalizacija
8,31 mrd. USD
Povprečni obseg
802,66 tis.
Razm. P/E
20,28
Dividendna donosnost
-
Primarna borza
NYSE
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 1,01 mrd. | −1,64 % |
Stroški poslovanja | 219,42 mio. | 5,38 % |
Čisti dohodek | 69,66 mio. | −20,29 % |
Čista dobičkovnost prihodkov | 6,90 | −18,92 % |
Earnings per share | 2,59 | −4,78 % |
EBITDA | 236,55 mio. | −4,13 % |
Efektivna davčna stopnja | 22,96 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 210,17 mio. | 33,72 % |
Skupna sredstva | 8,00 mrd. | 5,22 % |
Skupne obveznosti | 4,18 mrd. | −1,88 % |
Celoten lastniški kapital | 3,83 mrd. | — |
Shares outstanding | 51,14 mio. | — |
Razmerje P/B | 2,21 | — |
Donosnost sredstev | 4,65 % | — |
Donosnost kapitala | 5,62 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 69,66 mio. | −20,29 % |
Denar iz dejavnosti | 251,79 mio. | 22,56 % |
Denar iz naložb | −21,32 mio. | 73,20 % |
Denar iz financiranja | −207,54 mio. | −27,43 % |
Neto sprememba denarnih sredstev | 30,64 mio. | 170,98 % |
Prost denarni tok | 223,49 mio. | 120,91 % |
Vizitka
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry and offers support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe. The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories is often criticized by animal rights activists who condemn the company's usage of dogs and non-human primates for pharmaceutical purposes. The company is also a major harvester of horseshoe crab blood. Wikipedia
Generalni direktor
Datum ustanovitve
1947
Sedež organizacije
Spletno mesto
Zaposleni
21.100
